News
AstraZeneca (LSE:AZN) recently announced that its investigational antibody, anselamimab, did not achieve statistical ...
A promising new drug may finally bring hope to people suffering from a common but often overlooked cause of high blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback